Paper · 23533233
Clinical outcomes and molecular profile of differentiated thyroid cancers with radioiodine-avid distant metastases.
Sabra MM and 6 others. J Clin Endocrinol Metab, 2013. Cited by 96 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Clinical outcomes and molecular profile of differentiated thyroid cancers with radioiodine-avid distant metastases. Papers, record 23533233. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23533233
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics24
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adenocarcinoma, Follicular | Major topic |
| Gene Expression Regulation, Neoplastic | Major topic |
| Mutant Proteins | Major topic |
| Neoplasm Proteins | Major topic |
| Radiopharmaceuticals | Major topic |
| Thyroid Neoplasms | Major topic |
| Adolescent | |
| Adult | |
| Aged | |
| Aged, 80 and over | |
| Cohort Studies | |
| Combined Modality Therapy | |
| Female | |
| Follow-Up Studies | |
| Gene Expression Profiling | |
| Genes, ras | |
| Humans | |
| Iodine Radioisotopes | |
| Male | |
| Middle Aged | |
| Retrospective Studies | |
| Survival Analysis | |
| Thyroidectomy | |
| Young Adult |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| P30 CA008748 | NCI NIH HHS | United States | P30CA008748 | PubMed and NIH | NIH RePORTER |
| R01 CA050706 | NCI NIH HHS | United States | R01CA050706 | PubMed and NIH | NIH RePORTER |
| R01 CA072597 | NCI NIH HHS | United States | R01CA072597 | PubMed and NIH | NIH RePORTER |
| R01 CA72597 | NCI NIH HHS | United States | R01CA072597 | PubMed and NIH | NIH RePORTER |
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References18
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 3,745,409 | Long-term results of treatment of 283 patients with lung and bone metastases from differentiated thyroid carcinoma. | J Clin Endocrinol Metab | 1986 | https://conductscience.org/library/papers/3745409 | PubMed |
| 2 | 18,254,955 | Improved RNA quality and TaqMan Pre-amplification method (PreAmp) to enhance expression analysis from formalin fixed paraffin embedded (FFPE) materials. | BMC Biotechnol | 2008 | https://conductscience.org/library/papers/18254955 | PubMed |
| 3 | 22,827,641 | Clinical outcomes following empiric radioiodine therapy in patients with structurally identifiable metastatic follicular cell-derived thyroid carcinoma with negative diagnostic but positive post-therapy 131I whole-body scans. | Thyroid | 2012 | https://conductscience.org/library/papers/22827641 | PubMed |
| 4 | 19,416,908 | Endogenous expression of Hras(G12V) induces developmental defects and neoplasms with copy number imbalances of the oncogene. | Proc Natl Acad Sci U S A | 2009 | https://conductscience.org/library/papers/19416908 | PubMed |
| 5 | 17,655,865 | Rearrangement analysis in archival thyroid tissues: punching microdissection and artificial RET/PTC 1-12 transcripts. | J Surg Res | 2007 | https://conductscience.org/library/papers/17655865 | PubMed |
| 6 | 12,016,468 | Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940-1999): temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients. | World J Surg | 2002 | https://conductscience.org/library/papers/12016468 | PubMed |
| 7 | 18,682,506 | BRAF(V600E) mutation and outcome of patients with papillary thyroid carcinoma: a 15-year median follow-up study. | J Clin Endocrinol Metab | 2008 | https://conductscience.org/library/papers/18682506 | PubMed |
| 8 | 22,105,174 | Small-molecule MAPK inhibitors restore radioiodine incorporation in mouse thyroid cancers with conditional BRAF activation. | J Clin Invest | 2011 | https://conductscience.org/library/papers/22105174 | PubMed |
| 9 | 16,303,836 | Real-time prognosis for metastatic thyroid carcinoma based on 2-[18F]fluoro-2-deoxy-D-glucose-positron emission tomography scanning. | J Clin Endocrinol Metab | 2006 | https://conductscience.org/library/papers/16303836 | PubMed |
| 10 | 16,470,605 | Poorly differentiated thyroid carcinomas defined on the basis of mitosis and necrosis: a clinicopathologic study of 58 patients. | Cancer | 2006 | https://conductscience.org/library/papers/16470605 | PubMed |
1 to 10 of 18
See all 18 referencesCited by69
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 96 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,741,758 | How to manage radioiodine-refractory thyroid cancer in the era of precision medicine. | Drugs Context | 2026 | https://conductscience.org/library/papers/42741758 | PubMed |
| 42,315,928 | From bench to bedside: the evolving role of iodine in thyroid cancer management. | Nat Rev Endocrinol | 2026 | https://conductscience.org/library/papers/42315928 | PubMed |
| 42,272,787 | The dual axis of tumorigenesis: MAPK and PI3K/AKT pathways in papillary thyroid carcinoma. | Oncoscience | 2026 | https://conductscience.org/library/papers/42272787 | PubMed |
| 41,120,923 | Clinical outcomes by bone metastasis uptake pattern in differentiated thyroid cancer. | BMC Cancer | 2025 | https://conductscience.org/library/papers/41120923 | PubMed |
| 41,039,489 | CD44v6 expression in non-anaplastic thyroid carcinoma: characterization of candidates for targeted therapy. | Thyroid Res | 2025 | https://conductscience.org/library/papers/41039489 | PubMed |
| 40,585,286 | Brain metastasis from differentiated thyroid carcinoma responding to radioiodine therapy. | Asia Ocean J Nucl Med Biol | 2025 | https://conductscience.org/library/papers/40585286 | PubMed |
| 40,414,995 | Less is more: once vs. multiple radioactive iodine (RAI) therapy in patients with RAI-avid pulmonary micrometastatic differentiated thyroid cancer. | Eur J Nucl Med Mol Imaging | 2025 | https://conductscience.org/library/papers/40414995 | PubMed |
| 39,968,056 | Thyroid differentiation profile for differentiated thyroid cancer. | Endocr Oncol | 2025 | https://conductscience.org/library/papers/39968056 | PubMed |
| 39,336,882 | Detection of the BRAFV600E Mutation in Circulating Free Nucleic Acids as a Biomarker of Thyroid Cancer: A Review. | J Clin Med | 2024 | https://conductscience.org/library/papers/39336882 | PubMed |
| 39,225,945 | The value of preoperative molecular testing in the management of Bethesda V and Bethesda VI thyroid tumors. | Hormones (Athens) | 2025 | https://conductscience.org/library/papers/39225945 | PubMed |
1 to 10 of 69
See all 69 cited byGenes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| BRAF | 673 | PubTator's text mining | https://conductscience.org/library/genes/673 | NCBI Gene |
| PIK3CA | 5,290 | PubTator's text mining | https://conductscience.org/library/genes/5290 | NCBI Gene |
| RET | 5,979 | PubTator's text mining | https://conductscience.org/library/genes/5979 | NCBI Gene |
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/23533233
GET https://conductscience.org/api/papers/v1/23533233/cited_by?page=2